The biotech and pharmaceutical industries have had some big news in recent weeks. Here's what you should know to stay up-to-date.

The San Diego firm is scheduled to present positive preliminary data for two clinical studies of sitravatinib in non-small cell lung cancer at a symposium in Chicago on Friday.

These stocks are ready to break out and trade higher from current levels. Here's how to trade them from here.

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

These stocks look poised to break out and trade higher from current levels.

In the energy sector, 25% of the companies covered by Morningstar garnered fair-value increases of more than 10%.

After mass shootings, a lot of investors are saying enough if enough.

Nvidia stock is being bought on the dip. Here's how traders should approach it now.

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.